TP53 and neoplasm: There was no significant difference between ABCC4 expression and any of the clinicopathological factors including age, gender, tumor size, gross type, cell differentiation, serum CEA expression, serum CA19-9 expression, preoperative T stage, N stage and p53 type (χ2 test P>.05 for all) (Table 1).